Form 4 for EW Edwards Lifesciences
Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-13 · accession 0001225208-24-004205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-13 | 2024-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +14.5K | 54.0K | +37% | +$532.9K |
| D | 2024-03-13 | 2024-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $91.01 | -14.5K | 39.5K | -27% | -$1.32M |
| D | 2024-03-13 | 2024-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | -14.5K | 12.5K | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | M | A | 14,500 | $36.75 | 54,002.69 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-13 | S | D | 14,500 | $91.01 | 39,502.69 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $90.65 to $91.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2024-03-13 | M | D | 14,500 | $0.00 | 12,500 | D | $36.75 · 2017-06-11 to 2024-05-10 | 14,500 Common Stock |